POTASSIUM AND MAGNESIUM PREPARATIONS IN ROUTINE CLINICAL PRACTICE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Potassium and magnesium enter, in an important manner, into the regulation of cardiovascular and central nervous system functions, afford the normal course of numerous metabolic biochemical processes, control neuromuscular transmission, positively affect phosphorus and calcium metabolism, and maintain electrolyte balance in the body. Potassium and magnesium imbalance belongs to the most common electrolyte disorders. So the preparations of these macroelements are used in a wide range of indications in both the treatment of primarily cardiovascular diseases and the prevention of hypokalemia and hypomagnesemia particularly in patients taking diuretics (thiazide and especially loop ones) and/ or cardiac glycosides (digitalis preparations). It is appropriate to coadminister the salts of potassium and magnesium since the metabolism of the macroelements is closely related. Asparaginic acid potassium and magnesium salts have been widely used in clinical practice. Panangin is one of the most effective drugs that have a proper balance of potassium and magnesium.

Full Text

Restricted Access

About the authors

A. Kubynin

I.P. Pavlov Saint Petersburg State Medical University

Email: AKUB0310@yandex.ru
Candidate of Medical Sciences

References

  1. Вислобоков А.И., Игнатов Ю.Д., Мельников К.Н. Фармакологическая регуляция ионных каналов мембраны нейронов / СПб.: Изд-во СПбГМУ. -2006; 288 с.
  2. Лесиовская Е.Е., Бахтина С.М., Бойко И.Н. Витамины, макро- и микроэлементы / СПб.: изд-во СПбХФА. - 2004; 140 с.
  3. Трекова Н.А., Андрианова М.Ю., Толстова И.А., и др. Применение раствора калия и магния аспарагината для поддержания баланса калия и магния при кардиохирургических вмешательствах в условиях искусственного кровообращения // Анестез. и реаниматол. - 2008; 5: 17-21.
  4. Шестакова С.А., Долгодворов А.С., Кубынин А.Н. Нарушения водноэлектролитного обмена и их фармакологическая коррекция / СПб.: Изд-во СПбГМУ. - 2005; 91 с.
  5. Al-Delaimy W., Rimm E., Willett W. et al. Magnesium intake and risk of coronary heart disease among men // J. Am. Coll. Nutr. - 2004; 23 (1): 63-9.
  6. Ascherio A., Rimm E., Hernan M. et al. Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men // Circulation. - 1998; 98: 1198-204.
  7. Cooper W., Kuan P., Reuben S., Vanderburg M. Cardiac arrhythmias following acute myocardial infarction: Assosiation with serum potassium level and prior diuretic therapy // Eur. Heart J. - 1984; 5: 464-9.
  8. D’Elia L., Barba G., Cappuccio F., Strazzullo P. Potassium intake stroke and cardiovascular disease. A meta-analisys of prospective studies // J. Am. Coll. Cardiol. - 2011; 57: 1210-19.
  9. Dykcner T., Wester P. Relation between potassium, magnesiumand cardiac arrhythmias // Acta Med. Scand. Suppl. - 1981; 647: 163-9.
  10. Gettes L., Surawicz B. Effects of low and high concentrations of potassium on the simultaneously recorded Purkinje and ventricular action potentials of the perfused pig moderator band // Circ. Res. - 1968; 23: 717-29.
  11. Hoffman B., Suckling E. Effect of several cations on transmembrane potentials of cardiac muscle // Am. J. Physiol. - 1956; 186: 317-24.
  12. Hohnloser S., Verrier R., Lown B., Reader E. Effect of hypokalemia on susceptibility to ventricular fibrillation in the normal and ishemic canine heart // Am. Heart J. - 1986; 112: 32-5.
  13. Ito S., Surawicz B. Transient, «paradoxical» effects of increasing extracellular K+-concentration on transmembrane potential in canine cardiac Purkinje fibers // Circ. Res. - 1977; 41: 799-807.
  14. Keller P., Aronson R. The role of magnesium in cardiac arrhythmias // Prog. Cardiovasc. Dis. - 1990; 32: 433-48.
  15. Khaw K., Barrett-Connor E. Dietary potassium and stroke-associated mortality. A 12-year prospective population study // N. Engl. J. Med. - 1987; 316: 235-40.
  16. Kulick D., Hong R., Ryzen E. Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac disease // Am. Heart J. - 1988; 115: 367-73.
  17. Larsson S., Orsini N., Wolk A. Dietary potassium intake and risk of stroke. A dose-response meta-analysis of prospective studies // Stroke. - 2011; 42 (10): 2746-50.
  18. Nordrehaug J., Johanessen K., Von der Lippe G. Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction // Circulation. - 1985; 71: 645-49.
  19. Paice B., Paterson K., Onyanga-Omara F. et al. Record linkage study of hypokaliemia in hospitalized patients // Postgrad. Med. J. - 1986; 62: 187-91.
  20. Pelzer D., Trautwein W. Currents through ionic channels in multicellular cardiac tissue and single heart cells // Experentia. - 1987; 43: 1153-62.
  21. Sakmann B., Trube G. Conductance properties of single inwardly rectifying potassium channels in ventricular cells from guinea pig heart // J. Physiol. - 1984; 347: 641-57.
  22. Sarkkinen E., Kastarinen M., Niskanen T. et al. Feasibility and antihypertensive effect of replacing regular salt with mineral salt - rich in magnesium and potassium - in subjects with mildly elevated blood pressure // Nutr. J. - 2011; 10: 88.
  23. Schulman M., Narins R. Hypokalemia and cardiovascular disease // Am. J. Cardiol. - 1990; 65: 4-9.
  24. Sheu S., Korth M., Lathrop D.A. et al. Intra- and extra-cellular K+ and Na+ activities and resting membrane potential in sheep cardiac Purkinje strands // Circ. Res. - 1980; 47: 692-700.
  25. Soave P.M., Conti G., Costa R., Arcangeli A. Magnesium and anaesthesia // Curr. Drug Targets. - 2009; 10 (8): 734-43.
  26. Surawicz B. Relation between electrocardiogram and electrolites // Am. Heart J. - 1967; 73: 814-43.
  27. Surawicz B., Lepeschkin E., Herrlich H. Low and high magnesium concentrations at various calcium levels: Effect on the monophasic action potential, electrocardiogram and contractility of isolated rabbit hearts // Circ. Res. - 1961; 9: 811-8.
  28. Takanaka C., Ogunyankin K., Sarma J., Singh B. Antiarrhythmic and arrhythmogenic actions of varying levels of extracellular magnesium: Possible cellular basis for the differences in the efficacy of magnesium and lidocaine in torsades de pointes // J. Cardiovasc. Pharmacol. Ther. - 1997; 2: 125-34.
  29. Thompson R. Gobb L., Hypokalemia after resuscitation out-of-hospital ventricular fibrillation // JAMA. - 1982; 248: 2860-3.
  30. Tsuji H., Venditti F., Evans J., et al. The assiciations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham Heart Study) // Am. J. Cardiol. (US). - 1994; 74: 232-5.
  31. Yang T., Roden D. Extracellular potassium modulation of drug block of Ikr // Circulation. - 1996; 93: 407-11.
  32. Yang C. Calcium and magnesium in drinking water and risk of death from cerebrovascular disease // Stroke. - 1998; 29: 411-4.
  33. Zhu Y., Auerbach A. K+-occupancy of the n-methyl-d-aspartate receptor channel probed by Mg2+-block // J. Gen. Physiol. - 2001; 117(3): 287-98.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies